- Home
- NAMS vs BKD Comparison
NAMS vs BKD Comparison
Compare NAMS & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | BKD |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 2022 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NAMS | BKD |
|---|---|---|
| Price | $27.93 | $13.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $46.75 | $15.10 |
| AVG Volume (30 Days) | 1.1M | ★ 5.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.81 | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $22,503,000.00 | ★ $4,531,426,000.00 |
| Revenue This Year | $17.96 | N/A |
| Revenue Next Year | $540.65 | $4.30 |
| P/E Ratio | ★ N/A | $179.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.05 | $7.11 |
| 52 Week High | $42.21 | $17.09 |
Technical Indicators
Market Signals| Indicator | NAMS | BKD |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 34.89 |
| Support Level | $25.74 | $10.51 |
| Resistance Level | $37.29 | $14.21 |
| Average True Range (ATR) | 1.37 | 0.65 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 36.04 | 17.20 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.